Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1262
| Despition | CXCR4 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1411 | Human NDEL1 Protein (AC1411) | 2 µg | inquiry |
| ACPP-1392 | Human Dopa Decarboxylase Protein (AC1392) | 5 µg | inquiry |
| ACPP-1754 | Human VEGFC Protein, Sf9 (AC1754) | 2 µg | inquiry |
| ACPP-1664 | Human BLMH Protein (AC1664) | 5 µg | inquiry |
| ACPP-1659 | Human Visfatin Protein (AC1659) | 5 µg | inquiry |
| ACPP-1458 | Mouse LGALS3 Protein (AC1458) | 2 µg | inquiry |
| ACPP-1529 | Human KCTD4 Protein (AC1529) | 2 µg | inquiry |
| ACPP-1066 | Recombinant Human FGF2 Protein (Fc Tag) (AC1066) | 50 µg | inquiry |
| ACPP-1654 | Human ATXN3 Protein (AC1654) | 2 µg | inquiry |
| ACPP-1687 | Mouse Visfatin Protein (AC1687) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.